2026 AMR Guidance

Resource type
Web Page
Authors/contributors
Title
2026 AMR Guidance
Abstract
This updated IDSA AMR Guidance document provides treatment suggestions for infections caused by extended-spectrum β-lactamase–producing Enterobacterales (ESBL-E), AmpC β-lactamase–producing Enterobacterales (AmpC-E), carbapenem-resistant Enterobacterales (CRE), Pseudomonas aeruginosa with difficult-to-treat resistance (DTR P. aeruginosa), carbapenem-resistant Acinetobacter baumannii (CRAB), and Stenotrophomonas maltophilia.
Date
2026-07-30 7/30/26
Accessed
9/26/26, 3:18 PM
Language
en
Citation
Tamma, P. D., Bonomo, Robert A., Heil, Emily L., Justo, Julie Ann, Satlin, Michael J., & Mathers, Amy J. (2026, July 30). 2026 AMR Guidance. https://www.idsociety.org/practice-guideline/amr-guidance/
GUIDELINES